Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for INCY
Debby Gerald
28 Nov 15 14:21:52
RT @Drchik23: Largest % Inc in Short Int: $rvnc $gene $loxo $etrm $INCY $cytk $endp Largest % Dec: $aezs $dyax $zsph $rprx $life $biod $ame…
Michael Scally
28 Nov 15 09:47:17
RT @DewDiligence: $INCY CEO sold $25.6M of stock on 11/17/15-11/18/15 (exercising options that didn’t expire until 2019): https://t.co/B6K…
28 Nov 15 09:46:45
@WilliamGerber1 @DewDiligence Short Interest increased by ~1M shares in beg of Nov; 29% increase. Still very low % of float though. $incy
William Gerber
28 Nov 15 09:38:25
@DewDiligence Guess he thinks company is fully valued! $INCY
Roy Friedman
28 Nov 15 09:36:56
$INCY CEO sold $25.6M of stock on 11/17/15-11/18/15 (exercising options that didn’t expire until 2019): https://t.co/B6KmM681Cm
28 Nov 15 09:31:24
$INCY https://t.co/2DLqsIH0bF
Breaking News Now
27 Nov 15 20:58:10
$HSY $BF $INCY: Elite Investors Losing Their Taste For The Hershey Company (HSY): https://t.co/KopNIcVwUi
Brad Loncar
27 Nov 15 19:41:55
Today's installment of #ASH15 mail. From $AGIO $ALXN $GILD and $INCY. https://t.co/CKOGbokQLK
PennyStock Zone
27 Nov 15 16:34:50
https://t.co/gocGUCTb6U Best Trading software EVER! 60 Day back Guarantee! $INGN $INCY $BLOX $PXD #stocks #pennystocks
27 Nov 15 12:59:27
Nasdaq100 #Stocks Performance $NXPI $ILMN $SWKS $BIDU $AVGO $INCY $MDLZ $NFLX $AMAT $AAL $TSLA $NVDA $VRTX more@ https://t.co/YdSIjFJqHf
Ethan Weiss
27 Nov 15 11:36:37
Is this new? Ruxolitinib in pancreatic Ca - $incy https://t.co/A69A4kDLq9
27 Nov 15 09:35:51
we call Synergy Pharmaceuticals $SGYP will Hit 10 $ and more .https://t.co/OFVwlvKNzN … … … … … … $SGYP $ABUS $ISI $INCY $BMRN
27 Nov 15 09:18:28
Largest % Inc in Short Int: $rvnc $gene $loxo $etrm $INCY $cytk $endp Largest % Dec: $aezs $dyax $zsph $rprx $life $biod $amed $CELG $meip
27 Nov 15 08:51:42
Nasdaq100 #Stocks Trend $CHKP $MNST $ROST $ALXN $AMGN $AMAT $GILD $NXPI $VRTX $NFLX $VRSK $XLNX $FAST $INCY @ https://t.co/YdSIjFJqHf
27 Nov 15 08:51:25
Nasdaq100 #Stocks Performance $NXPI $ILMN $AAL $SWKS $INCY $AMAT $NFLX $EXPD $MDLZ $COST $NVDA $CTSH $HSIC more@ https://t.co/YdSIjFJqHf
Veronica Hardman
27 Nov 15 07:14:49
RT @bradloncar: Goldman summary: Buy- $BMRN ($158) $BLUE ($165) $INCY ($135) $KITE ($111) Sell- $SGEN ($33) Neutral- $ATRA ($38) $ISIS (…
27 Nov 15 04:39:12
$UPL $INCY: Active Trending Stocks: Cemex SAB de CV (ADR) (NYSE:CX), Ultra …: https://t.co/MwZ2n4t2mh
Breaking News Now
27 Nov 15 04:17:08
$XON $INCY: Biotech Stocks that your portfolio will love: Nektar Therapeutics …: https://t.co/52jM1jHNlF
Breaking News
27 Nov 15 04:14:14
$SN $INCY: The Best Shares to Buy: Sanchez Energy Corp (NYSE:SN), Incyte …: https://t.co/O0WfYKZGLh
27 Nov 15 04:13:10
$INCY $BBG $SN: The Best Shares to Buy: Sanchez Energy Corp (NYSE:SN), Incyte …: https://t.co/oLNG1Nv8JW
26 Nov 15 15:58:55
RT @alphatrends: why would anyone be surprised by a move like the one today in $INCY? know the personality fo what u trade #bipolar https:…
26 Nov 15 08:51:25
Nasdaq100 #Stocks Performance $GMCR $VIP $TSLA $EA $INCY $VIAB $MYL $MNST $ALXN $ILMN $VOD $AKAM $BBBY more@ https://t.co/YdSIjFJqHf
Breaking News
26 Nov 15 07:57:10
$AA $INCY: 3 Large Cap Stocks Are Just So Hot Right Now: Alcoa Inc (NYSE:AA …: https://t.co/q4hWYyX0Su
PennyStock Zone
26 Nov 15 07:38:22
https://t.co/gocGUCTb6U Best Trading software EVER! 60 Day back Guarantee! $INGN $INCY $BLOX $PXD #stocks #pennystocks
26 Nov 15 07:28:02
$ORCL $INCY: U.S Stocks Investor’s Alert – ArcelorMittal SA (NYSE:MT), Oracle …: https://t.co/lazfGSlGYq
26 Nov 15 06:30:04
$UN $INCY: Strong Buy Stocks for Investors: Unilever N.V. (ADR) (NYSE:UN …: https://t.co/0DjVgI0GJy
Breaking News
26 Nov 15 03:41:01
$INCY $AGN: Stocks with high institutional ownership: Incyte (INCY), Allergan PLC …: https://t.co/Sk1fQtUetJ
25 Nov 15 22:50:43
Black Friday $SALE on #stockmarket. Cash-rich, 5.7 EV/EBITDA, $60M stock buyback plan in Q4. Read: https://t.co/qM8kTQH7RQ $CERN $NU $INCY
Tom Loffman
25 Nov 15 19:49:06
Biggest gainers today large caps: $TSLA 5.22% $DE 4.79% $EA 3.65% $AA 3.52% $INCY 3.30% $HRL 3.13% $AEG 3.05% $PSO 2.88% $AGN 2.84%
25 Nov 15 18:16:17
@smallcapbiotech i.e. $alxn $abbv...matter of time before $incy and $sgen get acquired by the likes of $jnj or $mrk
25 Nov 15 16:01:55
Nasdaq100 #Stocks Performance $GMCR $VIP $TSLA $EA $INCY $VIAB $MYL $MNST $ALXN $ILMN $VOD $AKAM $BBBY more@ https://t.co/YdSIjFJqHf
25 Nov 15 15:45:03
$INCY is rated BUY, 14.6% upside by Wall Street analysts based on average ratings/targets https://t.co/X6z5BWCxcs https://t.co/HbPBHgQvqU
25 Nov 15 12:59:30
Nasdaq100 #Stocks Performance $GMCR $VIP $TSLA $EA $MNST $ALXN $MYL $ILMN $AKAM $BBBY $VOD $INCY $CHKP more@ https://t.co/YdSIjFJqHf
Ariel Silahian
25 Nov 15 12:16:36
Algo trading CLOSING signals: Nov/25 $INCY(3.2 %) $AZPN(1.5 %) $ACAS(7.4 %)
25 Nov 15 11:34:57
$SALE Undervalued cash-rich retailer due for gains on Black Friday; $60M stock buyback plan in Q4 https://t.co/qM8kTQpx0i $CERN $NU $INCY
Yu Zhu
25 Nov 15 10:39:11
RT @bradloncar: Goldman summary: Buy- $BMRN ($158) $BLUE ($165) $INCY ($135) $KITE ($111) Sell- $SGEN ($33) Neutral- $ATRA ($38) $ISIS (…
25 Nov 15 09:51:15
@BioInvestor2013 $SGYP 11/13/2015 27,254,248 SHORTS onboard ! SHORT SQUEEZE OUT !! $KBIO $SRPT $PFE $NVS $AMGN $ISIS $INCY
25 Nov 15 09:33:02
@BioInvestor2013 https://t.co/wGV3nVngqu $BLRX $SGYP $CPRX $SRPT $GILD $PFE $NVS $AMGN $ISIS $INO $KBIO $CLSN $CTIC $INCY $JNJN
25 Nov 15 09:25:12
https://t.co/iV2QQImkh2 insider trading ! $BLRX $SGYP $CPRX $SRPT $GILD $PFE $NVS $AMGN $ISIS $INO $KBIO $CLSN $CTIC $INCY
25 Nov 15 08:59:11
@BioInvestor2013 $TKMR $ORMP $INCY $BMRN $INO $CPRX we cal $TKMR and $ORMP 500% gain !! NOW we CAL $SGYP first step $ 10 $BLRX
25 Nov 15 07:43:02
$INCY: Wall Street analysts bullish on INCY's earnings growth: https://t.co/OJpFDnYbsP https://t.co/VewjQ7COTg
25 Nov 15 07:40:48
Commented on: "Healthcare ratings roundup" https://t.co/NK0Ciy9XNY $SCMP $BMRN $BLUE $INCY
25 Nov 15 06:48:39
November 25 Biotech Update $AGN $BMRN $GILD $INCY $MDCO https://t.co/tyxDvFKdxW
GTLackeyJr CMT
24 Nov 15 17:07:46
RS Movers https://t.co/6H5uu67H1j $RPV $PHDG $ITB $IHI $PTEN $AUY $SWHC $PLD $HAL $PPG $PANW $RRC $UBNT $SGEN $LH $INCY
Ariel Silahian
24 Nov 15 12:52:24
Algo trading: OPEN signals Nov/24 BUY: $INCY $NXTM $MAR $WSH $WTW $EDR $BDX $ACAS $OSUR $A $WTR $AZPN $HD $HRL $POZN $LOW $KSU
Yu Zhu
24 Nov 15 11:41:00
RT @MelissaLeeCNBC: $GILD- RBC calls it "defensive," w/ BIGGEST BALANCE SHEET IN BIOTECH. Could buy big like $VRTX $INCY but more likely sm…
john wright
24 Nov 15 11:40:11
RT @MelissaLeeCNBC: $GILD- RBC calls it "defensive," w/ BIGGEST BALANCE SHEET IN BIOTECH. Could buy big like $VRTX $INCY but more likely sm…
Melissa Lee
24 Nov 15 11:37:01
$GILD- RBC calls it "defensive," w/ BIGGEST BALANCE SHEET IN BIOTECH. Could buy big like $VRTX $INCY but more likely smaller mid-stage deal
Analyst Actions
24 Nov 15 04:12:01
$INCY: Analyst action by Goldman Sachs on Incyte: https://t.co/milh9OwenR https://t.co/dv4QwzMqIG
24 Nov 15 03:01:44
Weekly Nasdaq100 #Stocks Performance $NFLX $ROST $DLTR $TRIP $INTC $ATVI $VRTX $TSCO $AMGN $CA $AMZN $INCY more@ https://t.co/YdSIjFJqHf
  +Follow August 21, 2013 9:20AM



blog comments powered by Disqus

 Today's Must Reads

What Crowdfunding Leaders Are Saying About the SEC’s Approval of Title III

How the Drug Price Scrutiny is Affecting Pharma Stocks

8 More Tips for Choosing the Right Crowdfunding Platform

Will the Post-Smartphone Era Bring Wearable Drones?

3 Cloud Stocks That Pay Dividends


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register